Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Kura Oncology, Inc. (KURA) Institutional Ownership & Insider Trading

220 institutions reported holding Kura Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 41 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

KURAKura Oncology, Inc.Follow KURA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
854.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

220 institutions held 98.0% of the shares. Across filers that reported both quarters, shares held changed +2.8%.

Increased+88New+23Decreased-62Closed-18

Largest moves, shares (millions)

Arrowstreet Capital,…+1.4MAQR Capital Management+1.0MBlackRock+0.9MProsight Management-1.3MMillennium Management-0.9MPale Fire Capital SE-0.8M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.8Sep 24+2.1Dec 24+1.5Mar 25+1.4Jun 25+1.9Sep 25+1.6Dec 25-1.0Mar 26+2.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2622087+2.8%88236218
Mar 2621884-1.3%62228224
Dec 2521085+1.9%87375019
Sep 2519984+2.3%69375221
Jun 2518282+1.8%82264426
Mar 2518380+1.9%57335435
Dec 2418379+2.8%68353334
Sep 2417882+1.1%56165014

Kura Oncology, Inc. — questions

Who owns Kura Oncology, Inc. stock?
220 institutions reported Kura Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.8%), SUVRETTA CAPITAL MANAGEMENT, LLC (9.6%), BVF INC/IL (9.5%).
Are Kura Oncology, Inc. insiders buying or selling?
41 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Kura Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.